Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

CF · Q3 2025 Earnings

CF Industries

Reported November 5, 2025

30-second summary

Revenue grew 21% YoY to $1.66B with adjusted EBITDA of $667M and 97% YTD capacity utilization, while management raised FY2025 capex by $75M to $725M and introduced 2030 mid-cycle targets of ~$3B EBITDA and ~$2B FCF. The quietly important move: the "north of $100M annually" Donaldsonville CCS contribution figure that anchored last quarter's bull case is no longer disclosed, replaced by a decade-end $150-200M aggregate CCS+vertigris number. Bluepoint is now described as execution-ready with long-lead equipment procured and modular yard selection imminent, and management signaled buybacks will continue "aggressively" against what they frame as a structural valuation gap.

Headline numbers

EPS

Q3 FY2025

$2.19

Revenue

Q3 FY2025

$1.66B

+21.1% YoY

Gross margin

Q3 FY2025

38.1%

Key financials

Q3 FY2025

Metric	Q3 FY2025	YoY	Q2 FY2025	QoQ
Revenue	$1.66B	+21.1%	$1.89B	-12.2%
EPS	$2.19	—	$2.37	-7.6%
Gross margin	38.1%	—	39.9%	-180bps

Guidance

CF raised FY2025 capex guidance by $75M to $725M while introducing ambitious 2030 mid-cycle targets ($3B EBITDA, $2B FCF) and withdrawing near-term Donaldsonville CCS contribution guidance.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

New guidance

Metric	Period	Guide	YoY
Expected mid-cycle EBITDA	FY 2030	~$3,000 million	—
Expected mid-cycle free cash flow	FY 2030	~$2,000 million	—

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
CF-funded capital expenditures	FY 2025	~$650 million	~$725 million	+$75 million (+11.5%)	Raised
Incremental EBITDA and free cash flow from Donaldsonville CCS	FY 2025	North of $100 million annually	Withdrawn — no replacement	—	Withdrawn

Reaffirmed unchanged this quarter: Gross ammonia production (~10 million tons)

Other KPIs

Q3 FY2025

Segment	Q3 FY2025
Adjusted EBITDA	$667M
Natural Gas Cost (per MMBtu)	$2.96
Capacity Utilization (9M 2025)	97%
Q3 2025 LTM Free Cash Flow	$1.7B
LTM FCF/Adjusted EBITDA Conversion	65%
Safety Recordable Incident Rate (12-month rolling)	0.37 per 200k work hours
Gross Ammonia Production (2025F)	~10 million tons
Free Cash Flow Yield (Q3 2025 LTM)	12.0%

Management tone

Q4-2024 → Q1-2025 → Q2-2025 → Q3-2025: Project pipeline → CCS startup → CCS operating + structural tightening → 2030 horizon and execution discipline.

Last quarter Donaldsonville CCS was framed as a Q3 P&L event with a >$100M annual run-rate. This quarter that specific number is gone and the framing has migrated to "by the end of the decade, $150-200M annually from CCS plus vertigris." Anchor quote: "By the end of the decade, we expect the returns generated by our CCS projects, along with the vertigris abatement project, will add a consistent incremental $150 to $200 million to our free cash flow." The shift from "next quarter" to "end of decade" is either a reframing of an unchanged story or a quiet acknowledgment that 2025 contribution undershot the prior bar. Either way, the analyst burden of proof on near-term CCS economics just got harder.

The valuation-as-mispricing narrative hardened into operational policy. In Q2 management told Wolfe excess cash above LRP goes to "more aggressive" buybacks; this quarter it became: "we will continue aggressively repurchasing shares from the non-believers and those that don't take the time to understand why we are fundamentally different." The language escalated from capital allocation discipline to a confrontational stance toward the market. With LTM FCF yield at 12.0% disclosed, buybacks are now framed as the primary mechanism for closing the gap, not a residual after capex.

Blue Point transitioned from "JV signed with Linde" (Q2) to procurement complete and modular yard selection imminent (Q3). Anchor: "the modular equipment... we'll be selecting the modular yard here shortly, and those have been fixed fee bids... we still feel very confident about." Fixed-fee modular bids are a meaningful de-risking event for a project of this scale and reduce the variance around the 2030 EBITDA targets that are now doing the heavy lifting in the bull case.

The nitrogen demand thesis sharpened from "structural tightening" (Q2) to "completely inelastic to grower profitability" (Q3). Anchor: "Even in periods of relatively weak grower profitability, Nitrogen demand is unaffected, almost completely inelastic." This is management directly attacking the analyst frame that CF trades with the ag cycle, and is consistent with the +21% revenue print despite well-publicized 2025 grower-margin pressure.

European supply tightness has moved from forecast to confirmed-ahead-of-schedule: from 48 ammonia assets pre-cycle to ~30-31 today, with another 4-5 expected to close, and "we're probably ahead of that particular schedule." This is now table stakes for the multi-year margin regime call.

Recurring themes management leaned on this quarter:

Nitrogen demand inelasticity despite ag headwindsLow-carbon ammonia differentiation and premium pricingEuropean supply tightening from plant closuresFree cash flow conversion and shareholder returns disciplineBluepoint project execution readiness and return profilesCCS/45Q tax credit monetization ($150-200M annual incremental FCF by decade end)

Risks management surfaced:

Yazoo City incident operational impact (timing unclear but ammonia plant still operating)Tariff escalation on long-lead equipment and modular construction (partially hedged in contingency)European TTF gas price volatility making seasonal production economics riskyChina export quota execution and domestic demand absorptionPlant startup delays in other global producers creating supply uncertainty

Answers to last quarter's watch list

Donaldsonville CCS EBITDA accrual in Q3 — The >$100M annual disclosure was withdrawn this quarter; segment-level CCS economics are not broken out in the release, and the framing has shifted to "$150-200M by end of decade" inclusive of vertigris. Without transcript Q&A on realized 45Q volumes or premium ammonia pricing, the prior bar cannot be verified. Status: Not resolved

Low-carbon ammonia premium quantification — Management's pre-release commentary (per tone analysis) cited a $20-25/ton premium with potential matching as supply tightens, and called it "an extra 50% that was never initially part of the justification." This is the first explicit per-ton premium disclosure. Status: Resolved positively

Q3 turnaround impact on production volumes — 9M capacity utilization came in at 97% versus 99% in Q2, consistent with the "couple hundred thousand tons lower" Q3 guide. The ~10M ton FY production guide was reaffirmed, so turnarounds tracked to plan. Status: Resolved positively

Buyback pace vs. $2.4B authorization — Specific Q3 buyback dollars not disclosed in the press release excerpt, but management's tone escalated from "more aggressive if FCF exceeds LRP" to actively repurchasing "from the non-believers." Directionally on-thesis but unverified on magnitude. Status: Continue monitoring

2026 setup commentary — Constructive framing intact: "global supply-demand balance expected to tighten as demand outpaces global nitrogen capacity growth," with European closures ahead of schedule (3-4M tons confirmed offline). The Q2 caution on 2026 has softened toward "remain constructive." Status: Resolved positively

Blue Point capex trajectory — FY2025 Blue Point capex held at ~$150M but total FY capex raised $75M to $725M, suggesting other capex categories absorbed the increase, not Blue Point pull-forward. Site construction still expected to begin in 2026. Status: Continue monitoring

What to watch into next quarter

Whether the withdrawn Donaldsonville CCS >$100M annual figure resurfaces in Q4 disclosure with realized 2025 economics — silence on actual 45Q credits booked and low-carbon ammonia tons shipped at premium would confirm the reframing is more than cosmetic.

Q4 buyback dollars vs. the $2.4B authorization remaining as of Q2 — given the escalated "non-believers" rhetoric, anything under ~$400M of Q4 buyback would read as inconsistent with the messaging.

FY2025 capex landing at the new $725M guide or creeping further — a second consecutive raise without explicit Blue Point pull-forward would suggest contingency or scope creep on the base business.

Gross margin trajectory in Q4 with gas cost likely staying favorable — Q3 saw 180bps QoQ compression despite gas falling 12%; if Q4 doesn't recover with the ag-weighted order book management cited last quarter, the pricing story weakens.

2030 mid-cycle target sensitivities — the new ~$3B EBITDA / ~$2B FCF anchors are now the headline numbers; watch for any qualitative softening on Blue Point timing, CCS contribution mix, or 45Q credit assumptions that would alter the path.

Yazoo City incident operational follow-up — the tone analysis flagged it as a risk with "timing unclear"; watch for explicit insurance recovery, production impact, or restart commentary.

Sources

CF Industries Q3-2025 press release (SEC EX-99.1): https://www.sec.gov/Archives/edgar/data/1324404/000110465925107103/tm2530157d1_ex99-1.htm
CF Industries Q2-2025 prior-quarter brief (Tapebrief)

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.